Characterization	O
of	O
the	O
Effect	O
of	O
Drug	B:C0687133
-	I:C0687133
Drug	I:C0687133
Interaction	I:C0687133
on	O
Protein	O
Binding	I:C0033618
in	O
Concurrent	O
Administration	O
of	O
Sulfamethoxazol	O
and	O
Diclofenac	O
Sodium	I:C0700583
Using	O
Bovine	O
Serum	I:C0036774
Albumin	I:C0036774
Purpose	O
:	O

Characterization	O
of	O
the	O
Effect	O
of	O
Drug	O
-	I:C0687133
Drug	I:C0687133
Interaction	I:C0687133
on	O
Protein	B:C0033618
Binding	I:C0033618
in	O
Concurrent	O
Administration	O
of	O
Sulfamethoxazol	O
and	O
Diclofenac	O
Sodium	I:C0700583
Using	O
Bovine	O
Serum	I:C0036774
Albumin	I:C0036774
Purpose	O
:	O

Characterization	O
of	O
the	O
Effect	O
of	O
Drug	O
-	I:C0687133
Drug	I:C0687133
Interaction	I:C0687133
on	O
Protein	O
Binding	I:C0033618
in	O
Concurrent	O
Administration	B:C1533734
of	O
Sulfamethoxazol	O
and	O
Diclofenac	O
Sodium	I:C0700583
Using	O
Bovine	O
Serum	I:C0036774
Albumin	I:C0036774
Purpose	O
:	O

Characterization	O
of	O
the	O
Effect	O
of	O
Drug	O
-	I:C0687133
Drug	I:C0687133
Interaction	I:C0687133
on	O
Protein	O
Binding	I:C0033618
in	O
Concurrent	O
Administration	O
of	O
Sulfamethoxazol	B:C0038689
and	O
Diclofenac	O
Sodium	I:C0700583
Using	O
Bovine	O
Serum	I:C0036774
Albumin	I:C0036774
Purpose	O
:	O

Characterization	O
of	O
the	O
Effect	O
of	O
Drug	O
-	I:C0687133
Drug	I:C0687133
Interaction	I:C0687133
on	O
Protein	O
Binding	I:C0033618
in	O
Concurrent	O
Administration	O
of	O
Sulfamethoxazol	O
and	O
Diclofenac	B:C0700583
Sodium	I:C0700583
Using	O
Bovine	O
Serum	I:C0036774
Albumin	I:C0036774
Purpose	O
:	O

Characterization	O
of	O
the	O
Effect	O
of	O
Drug	O
-	I:C0687133
Drug	I:C0687133
Interaction	I:C0687133
on	O
Protein	O
Binding	I:C0033618
in	O
Concurrent	O
Administration	O
of	O
Sulfamethoxazol	O
and	O
Diclofenac	O
Sodium	I:C0700583
Using	O
Bovine	B:C0036774
Serum	I:C0036774
Albumin	I:C0036774
Purpose	O
:	O

This	O
project	O
was	O
aimed	O
to	O
determine	O
the	O
effect	O
of	O
concurrent	O
administration	B:C1533734
of	O
sulfamethoxazole	O
and	O
diclofenac	O
sodium	I:C0700583
.	O

This	O
project	O
was	O
aimed	O
to	O
determine	O
the	O
effect	O
of	O
concurrent	O
administration	O
of	O
sulfamethoxazole	B:C0038689
and	O
diclofenac	O
sodium	I:C0700583
.	O

This	O
project	O
was	O
aimed	O
to	O
determine	O
the	O
effect	O
of	O
concurrent	O
administration	O
of	O
sulfamethoxazole	O
and	O
diclofenac	B:C0700583
sodium	I:C0700583
.	O

Methods	O
:	O
Equilibrium	B:C0022885
dialysis	I:C0022885
method	I:C0022885
was	O
adopted	O
to	O
study	O
different	O
protein	O
binding	I:C0033618
aspects	I:C0033618
of	O
sulfamethoxazole	O
and	O
diclofenac	O
sodium	I:C0700583
.	O

Methods	O
:	O
Equilibrium	O
dialysis	I:C0022885
method	I:C0022885
was	O
adopted	O
to	O
study	B:C2603343
different	O
protein	O
binding	I:C0033618
aspects	I:C0033618
of	O
sulfamethoxazole	O
and	O
diclofenac	O
sodium	I:C0700583
.	O

Methods	O
:	O
Equilibrium	O
dialysis	I:C0022885
method	I:C0022885
was	O
adopted	O
to	O
study	O
different	O
protein	B:C0033618
binding	I:C0033618
aspects	I:C0033618
of	O
sulfamethoxazole	O
and	O
diclofenac	O
sodium	I:C0700583
.	O

Methods	O
:	O
Equilibrium	O
dialysis	I:C0022885
method	I:C0022885
was	O
adopted	O
to	O
study	O
different	O
protein	O
binding	I:C0033618
aspects	I:C0033618
of	O
sulfamethoxazole	B:C0038689
and	O
diclofenac	O
sodium	I:C0700583
.	O

Methods	O
:	O
Equilibrium	O
dialysis	I:C0022885
method	I:C0022885
was	O
adopted	O
to	O
study	O
different	O
protein	O
binding	I:C0033618
aspects	I:C0033618
of	O
sulfamethoxazole	O
and	O
diclofenac	B:C0700583
sodium	I:C0700583
.	O

Results	O
:	O
Sulfamethoxazole	B:C0038689
showed	O
two	O
types	O
of	O
association	O
constants	O
;	O
high	O
affinity	O
constant	O
29.0±0.20	O
×10	O
(	O
6	O
)	O
M(	O
-	O
1	O
)	O
with	O
lower	O
number	O
of	O
binding	O
sites	I:C1514562
of	O
0.7±1	O
and	O
low	O
affinity	O
constant	O
1.13±0.20	O
×10	O
(	O
6	O
)	O
M(	O
-	O
1	O
)	O
with	O
higher	O
number	O
of	O
binding	O
sites	I:C1514562
of	O
3.45±1	O
at	O
pH	O
7.4	O
and	O
40	O
°C	O
temperature	O
.	O

Results	O
:	O
Sulfamethoxazole	O
showed	O
two	O
types	O
of	O
association	O
constants	O
;	O
high	O
affinity	O
constant	O
29.0±0.20	O
×10	O
(	O
6	O
)	O
M(	O
-	O
1	O
)	O
with	O
lower	O
number	O
of	O
binding	B:C1514562
sites	I:C1514562
of	O
0.7±1	O
and	O
low	O
affinity	O
constant	O
1.13±0.20	O
×10	O
(	O
6	O
)	O
M(	O
-	O
1	O
)	O
with	O
higher	O
number	O
of	O
binding	O
sites	I:C1514562
of	O
3.45±1	O
at	O
pH	O
7.4	O
and	O
40	O
°C	O
temperature	O
.	O

Results	O
:	O
Sulfamethoxazole	O
showed	O
two	O
types	O
of	O
association	O
constants	O
;	O
high	O
affinity	O
constant	O
29.0±0.20	O
×10	O
(	O
6	O
)	O
M(	O
-	O
1	O
)	O
with	O
lower	O
number	O
of	O
binding	O
sites	I:C1514562
of	O
0.7±1	O
and	O
low	O
affinity	O
constant	O
1.13±0.20	O
×10	O
(	O
6	O
)	O
M(	O
-	O
1	O
)	O
with	O
higher	O
number	O
of	O
binding	B:C1514562
sites	I:C1514562
of	O
3.45±1	O
at	O
pH	O
7.4	O
and	O
40	O
°C	O
temperature	O
.	O

Diclofenac	B:C0700583
sodium	I:C0700583
showed	O
high	O
affinity	O
constant	O
33.66±0.20	O
×10	O
(	O
6	O
)	O
M(	O
-	O
1	O
)	O
with	O
lower	O
number	O
of	O
binding	O
sites	I:C1514562
of	O
1.01±1	O
and	O
low	O
affinity	O
constant	O
1.72±0.20	O
×10	O
(	O
6	O
)	O
M(	O
-	O
1	O
)	O
with	O
higher	O
number	O
of	O
binding	O
sites	I:C1514562
of	O
6.40±1	O
at	O
the	O
same	O
condition	O
.	O

Diclofenac	O
sodium	I:C0700583
showed	O
high	O
affinity	O
constant	O
33.66±0.20	O
×10	O
(	O
6	O
)	O
M(	O
-	O
1	O
)	O
with	O
lower	O
number	O
of	O
binding	B:C1514562
sites	I:C1514562
of	O
1.01±1	O
and	O
low	O
affinity	O
constant	O
1.72±0.20	O
×10	O
(	O
6	O
)	O
M(	O
-	O
1	O
)	O
with	O
higher	O
number	O
of	O
binding	O
sites	I:C1514562
of	O
6.40±1	O
at	O
the	O
same	O
condition	O
.	O

Diclofenac	O
sodium	I:C0700583
showed	O
high	O
affinity	O
constant	O
33.66±0.20	O
×10	O
(	O
6	O
)	O
M(	O
-	O
1	O
)	O
with	O
lower	O
number	O
of	O
binding	O
sites	I:C1514562
of	O
1.01±1	O
and	O
low	O
affinity	O
constant	O
1.72±0.20	O
×10	O
(	O
6	O
)	O
M(	O
-	O
1	O
)	O
with	O
higher	O
number	O
of	O
binding	B:C1514562
sites	I:C1514562
of	O
6.40±1	O
at	O
the	O
same	O
condition	O
.	O

Site	O
specific	O
probe	O
displacement	O
data	O
implied	O
that	O
site	B:C1514562
-	I:C1514562
I	I:C1514562
,	O
warfarin	O
sodium	I:C0376218
site	O
,	O
was	O
the	O
high	O
affinity	I:C1514562
site	I:C1514562
,	O
while	O
site	O
-	I:C1514562
II	I:C1514562
,	O
diazepam	O
site	O
,	O
was	O
the	O
low	O
affinity	I:C1514562
site	I:C1514562
for	O
these	O
drugs	O
.	O

Site	O
specific	O
probe	O
displacement	O
data	O
implied	O
that	O
site	O
-	I:C1514562
I	I:C1514562
,	O
warfarin	B:C0376218
sodium	I:C0376218
site	O
,	O
was	O
the	O
high	O
affinity	I:C1514562
site	I:C1514562
,	O
while	O
site	O
-	I:C1514562
II	I:C1514562
,	O
diazepam	O
site	O
,	O
was	O
the	O
low	O
affinity	I:C1514562
site	I:C1514562
for	O
these	O
drugs	O
.	O

Site	O
specific	O
probe	O
displacement	O
data	O
implied	O
that	O
site	O
-	I:C1514562
I	I:C1514562
,	O
warfarin	O
sodium	I:C0376218
site	B:C1514562
,	O
was	O
the	O
high	O
affinity	I:C1514562
site	I:C1514562
,	O
while	O
site	O
-	I:C1514562
II	I:C1514562
,	O
diazepam	O
site	O
,	O
was	O
the	O
low	O
affinity	I:C1514562
site	I:C1514562
for	O
these	O
drugs	O
.	O

Site	O
specific	O
probe	O
displacement	O
data	O
implied	O
that	O
site	O
-	I:C1514562
I	I:C1514562
,	O
warfarin	O
sodium	I:C0376218
site	O
,	O
was	O
the	O
high	B:C1514562
affinity	I:C1514562
site	I:C1514562
,	O
while	O
site	O
-	I:C1514562
II	I:C1514562
,	O
diazepam	O
site	O
,	O
was	O
the	O
low	O
affinity	I:C1514562
site	I:C1514562
for	O
these	O
drugs	O
.	O

Site	O
specific	O
probe	O
displacement	O
data	O
implied	O
that	O
site	O
-	I:C1514562
I	I:C1514562
,	O
warfarin	O
sodium	I:C0376218
site	O
,	O
was	O
the	O
high	O
affinity	I:C1514562
site	I:C1514562
,	O
while	O
site	B:C1514562
-	I:C1514562
II	I:C1514562
,	O
diazepam	O
site	O
,	O
was	O
the	O
low	O
affinity	I:C1514562
site	I:C1514562
for	O
these	O
drugs	O
.	O

Site	O
specific	O
probe	O
displacement	O
data	O
implied	O
that	O
site	O
-	I:C1514562
I	I:C1514562
,	O
warfarin	O
sodium	I:C0376218
site	O
,	O
was	O
the	O
high	O
affinity	I:C1514562
site	I:C1514562
,	O
while	O
site	O
-	I:C1514562
II	I:C1514562
,	O
diazepam	B:C0012010
site	O
,	O
was	O
the	O
low	O
affinity	I:C1514562
site	I:C1514562
for	O
these	O
drugs	O
.	O

Site	O
specific	O
probe	O
displacement	O
data	O
implied	O
that	O
site	O
-	I:C1514562
I	I:C1514562
,	O
warfarin	O
sodium	I:C0376218
site	O
,	O
was	O
the	O
high	O
affinity	I:C1514562
site	I:C1514562
,	O
while	O
site	O
-	I:C1514562
II	I:C1514562
,	O
diazepam	O
site	B:C1514562
,	O
was	O
the	O
low	O
affinity	I:C1514562
site	I:C1514562
for	O
these	O
drugs	O
.	O

Site	O
specific	O
probe	O
displacement	O
data	O
implied	O
that	O
site	O
-	I:C1514562
I	I:C1514562
,	O
warfarin	O
sodium	I:C0376218
site	O
,	O
was	O
the	O
high	O
affinity	I:C1514562
site	I:C1514562
,	O
while	O
site	O
-	I:C1514562
II	I:C1514562
,	O
diazepam	O
site	O
,	O
was	O
the	O
low	B:C1514562
affinity	I:C1514562
site	I:C1514562
for	O
these	O
drugs	O
.	O

Site	O
specific	O
probe	O
displacement	O
data	O
implied	O
that	O
site	O
-	I:C1514562
I	I:C1514562
,	O
warfarin	O
sodium	I:C0376218
site	O
,	O
was	O
the	O
high	O
affinity	I:C1514562
site	I:C1514562
,	O
while	O
site	O
-	I:C1514562
II	I:C1514562
,	O
diazepam	O
site	O
,	O
was	O
the	O
low	O
affinity	I:C1514562
site	I:C1514562
for	O
these	O
drugs	B:C1254351
.	O

During	O
concurrent	O
administration	B:C1533734
,	O
sulfamethoxazole	O
increased	O
the	O
free	O
concentration	O
of	O
diclofenac	O
sodium	I:C0700583
from	O
17.5±0.14	O
%	O
to	O
70.0±0.014	O
%	O
in	O
absence	O
and	O
from	O
22.5±0.07	O
%	O
to	O
83.0±0.014	O
%	O
in	O
presence	O
of	O
site	O
-	I:C0026381
I	I:C0026381
specific	I:C0026381
probe	I:C0026381
.	O

During	O
concurrent	O
administration	O
,	O
sulfamethoxazole	B:C0038689
increased	O
the	O
free	O
concentration	O
of	O
diclofenac	O
sodium	I:C0700583
from	O
17.5±0.14	O
%	O
to	O
70.0±0.014	O
%	O
in	O
absence	O
and	O
from	O
22.5±0.07	O
%	O
to	O
83.0±0.014	O
%	O
in	O
presence	O
of	O
site	O
-	I:C0026381
I	I:C0026381
specific	I:C0026381
probe	I:C0026381
.	O

During	O
concurrent	O
administration	O
,	O
sulfamethoxazole	O
increased	O
the	O
free	O
concentration	O
of	O
diclofenac	B:C0700583
sodium	I:C0700583
from	O
17.5±0.14	O
%	O
to	O
70.0±0.014	O
%	O
in	O
absence	O
and	O
from	O
22.5±0.07	O
%	O
to	O
83.0±0.014	O
%	O
in	O
presence	O
of	O
site	O
-	I:C0026381
I	I:C0026381
specific	I:C0026381
probe	I:C0026381
.	O

During	O
concurrent	O
administration	O
,	O
sulfamethoxazole	O
increased	O
the	O
free	O
concentration	O
of	O
diclofenac	O
sodium	I:C0700583
from	O
17.5±0.14	O
%	O
to	O
70.0±0.014	O
%	O
in	O
absence	O
and	O
from	O
22.5±0.07	O
%	O
to	O
83.0±0.014	O
%	O
in	O
presence	B:C0150312
of	O
site	O
-	I:C0026381
I	I:C0026381
specific	I:C0026381
probe	I:C0026381
.	O

During	O
concurrent	O
administration	O
,	O
sulfamethoxazole	O
increased	O
the	O
free	O
concentration	O
of	O
diclofenac	O
sodium	I:C0700583
from	O
17.5±0.14	O
%	O
to	O
70.0±0.014	O
%	O
in	O
absence	O
and	O
from	O
22.5±0.07	O
%	O
to	O
83.0±0.014	O
%	O
in	O
presence	O
of	O
site	B:C0026381
-	I:C0026381
I	I:C0026381
specific	I:C0026381
probe	I:C0026381
.	O

Diclofenac	B:C0700583
sodium	I:C0700583
also	O
increased	O
the	O
free	O
concentration	O
of	O
sulfamethoxazole	O
from	O
2.8±0.07	O
%	O
to	O
52.0±0.14	O
%	O
and	O
from	O
8.5±0.014	O
%	O
to	O
64.4±0.07	O
%	O
in	O
absence	O
and	O
presence	O
of	O
site	O
-	I:C0026381
I	I:C0026381
specific	I:C0026381
probe	I:C0026381
respectively	O
.	O

Diclofenac	O
sodium	I:C0700583
also	O
increased	O
the	O
free	O
concentration	O
of	O
sulfamethoxazole	B:C0038689
from	O
2.8±0.07	O
%	O
to	O
52.0±0.14	O
%	O
and	O
from	O
8.5±0.014	O
%	O
to	O
64.4±0.07	O
%	O
in	O
absence	O
and	O
presence	O
of	O
site	O
-	I:C0026381
I	I:C0026381
specific	I:C0026381
probe	I:C0026381
respectively	O
.	O

Diclofenac	O
sodium	I:C0700583
also	O
increased	O
the	O
free	O
concentration	O
of	O
sulfamethoxazole	O
from	O
2.8±0.07	O
%	O
to	O
52.0±0.14	O
%	O
and	O
from	O
8.5±0.014	O
%	O
to	O
64.4±0.07	O
%	O
in	O
absence	O
and	O
presence	B:C0150312
of	O
site	O
-	I:C0026381
I	I:C0026381
specific	I:C0026381
probe	I:C0026381
respectively	O
.	O

Diclofenac	O
sodium	I:C0700583
also	O
increased	O
the	O
free	O
concentration	O
of	O
sulfamethoxazole	O
from	O
2.8±0.07	O
%	O
to	O
52.0±0.14	O
%	O
and	O
from	O
8.5±0.014	O
%	O
to	O
64.4±0.07	O
%	O
in	O
absence	O
and	O
presence	O
of	O
site	B:C0026381
-	I:C0026381
I	I:C0026381
specific	I:C0026381
probe	I:C0026381
respectively	O
.	O

The	O
study	B:C2603343
revealed	O
that	O
the	O
concurrent	O
administration	O
of	O
sulfamethoxazole	O
and	O
diclofenac	O
sodium	I:C0700583
may	O
result	O
drug	O
concentration	O
alteration	O
in	O
blood	O
.	O

The	O
study	O
revealed	O
that	O
the	O
concurrent	O
administration	B:C1533734
of	O
sulfamethoxazole	O
and	O
diclofenac	O
sodium	I:C0700583
may	O
result	O
drug	O
concentration	O
alteration	O
in	O
blood	O
.	O

The	O
study	O
revealed	O
that	O
the	O
concurrent	O
administration	O
of	O
sulfamethoxazole	B:C0038689
and	O
diclofenac	O
sodium	I:C0700583
may	O
result	O
drug	O
concentration	O
alteration	O
in	O
blood	O
.	O

The	O
study	O
revealed	O
that	O
the	O
concurrent	O
administration	O
of	O
sulfamethoxazole	O
and	O
diclofenac	B:C0700583
sodium	I:C0700583
may	O
result	O
drug	O
concentration	O
alteration	O
in	O
blood	O
.	O

The	O
study	O
revealed	O
that	O
the	O
concurrent	O
administration	O
of	O
sulfamethoxazole	O
and	O
diclofenac	O
sodium	I:C0700583
may	O
result	O
drug	O
concentration	O
alteration	O
in	O
blood	B:C0005767
.	O

